The mission of The DOLF Project is to develop and test improved treatments for onchocerciasis and lymphatic filariasis that will enhance efforts to control and eliminate these important neglected tropical diseases.

NEWS & EVENTS


Open Positions for Postdoctoral Fellows

Postdoctoral Fellowship 1: Translational research on lymphatic filariasis and onchocerciasis The Infectious Diseases Division of the Washington University School of Medicine in St. Louis has support from the Bill & Melinda Gates Foundation for research related to the elimination programs for lymphatic filariasis and onchocerciasis (see www.dolfproject.wustl.edu). We are seeking a postdoctoral fellow to perform […]
New clinical trial for treatment of LF in Cote d’Ivoire

New clinical trial for treatment of LF in Cote d’Ivoire

DOLF project studies have demonstrated the safety and superior efficacy of IDA (a triple drug regimen of ivermectin, DEC, and albendazole) for treatment of lymphatic filariasis (LF). Moxidectin is a new drug that was recently approved for treatment of onchocerciasis. It is more effective than ivermectin for long-term clearance of O. volvulus parasites from the […]

DOLF Project Ophthalmologists Publish Short Case Report

DOLF project ophthalmologists Michael Gyasi and Augustine Hong have published a short case report of a patient with ocular onchocerciasis. This includes a photo and a very interesting video with motile microfilariae in the anterior chamber of the eye (open access, see “supplements”) that people may want to use for teaching or social mobilization. Microfilarial […]
  • Cote d'Ivoire